Foundation for Taxpayer and Consumer Rights Supports Lee-Halpern Petition
By Jerry Flanagan
| 02. 16. 2005
Robert Klein
Chair
Independent Citizen's Oversight Committee
Mr. Klein,
The eyes of the world are on California. New medical treatments and funding strategies developed in the world's sixth leading economy will become national models. The success or failure of the California experiment could decide the fate of stem cell research for years to come.
We are writing to express our deep concern with the failure of the California Institute for Regenerative Medicine ("CIRM") and Independent Citizen's Oversight Committee ("ICOC") to guarantee an open, democratic decision-making process and disregard of state conflict of interest laws. The Foundation for Taxpayer and Consumer Rights (FTCR) calls on the CIRM and ICOC to support the petition filed by Philip R. Lee, MD, and Charles Halpern, JD.
When voters approved the unprecedented $3 billion in taxpayer-funded bonds to support stem cell research, they did so to provide access to innovative medical technologies for all Californians. However, the public availability of new medical technologies is threatened by a web of conflicts between those responsible for awarding research grants and the biotech and pharmaceutical companies who stand...
Related Articles
By Staff, National Women's Law Center | 08.13.2025
INTRODUCTION
Baby bonuses. Motherhood medals. Fertility tracking. You may have heard of these policy proposals as solutions from the Trump administration to help encourage women to have more children.
Besides falling short of ensuring that people have what they need...
By Zusha Elinson, The Wall Street Journal | 08.12.2025
BERKELEY, Calif.—Tsvi Benson-Tilsen, a mathematician, spent seven years researching how to keep an advanced form of artificial intelligence from destroying humanity before he concluded that stopping it wasn’t possible—at least anytime soon.
Now, he’s turned his considerable brainpower to promoting...
By Cade Metz, The New York Times | 08.04.2025
Image by Mike MacKenzie / CC BY 2.0
In downtown Berkeley, an old hotel has become a temple to the pursuit of artificial intelligence and the future of humanity. Its name is Lighthaven.
Covering much of a city block, this...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...